Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P14784 (
IL-2 receptor
)
3,849
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Human T lymphocyte proliferation induced by neuraminidase-galactose oxidase (NAGO)-treated autologous erythrocytes (HENAGO) plus polyethylene glycol (PEG) has previously been shown to be independent of accessory cells. Here, we show that the response to HENAGO + PEG was accompanied by interleukin 2 (IL-2) release and was inhibited by anti-IL-2 and anti-
IL-2 receptor
antibodies. HENAGO alone initiated DNA synthesis together with phorbol ester (12-O-tetradecanoyl-phorbol-13-acetate; TPA). To elucidate the nature of the stimulatory signals NAGO-treated sheep erythrocytes (SENAGO) were used in additional experiments. In parallel to the superior rosetting capacity of SE compared to HE. SENAGO were by themselves stimulatory, and the response was further enhanced by PEG or TPA. Antibody L180/1, specific for the T11 (CD2) target structure (T11TS) on SE, homologous to the human CD2 ligand LFA-3, abolished the response to SENAGO alone or when combined with PEG or TPA. The results suggest that ENAGO induce T-cell response through CD2-LFA-3-T11TS interaction, and via other surface antigens bound by the oxidatively induced
aldehyde
groups on ENAGO.
...
PMID:Activation of human T cells by neuraminidase-galactose oxidase-treated erythrocytes involving CD2 (T11) and its complementary structure. 289 54
Variable immunobiological changes occur with alcohol consumption. Previous studies have shown that
acetaldehyde
forms stable adducts with serum proteins, including albumin. These adducts are elevated in persons and animals consuming ethanol. We examined the effect of serum protein-
acetaldehyde
adducts formed with fetal bovine serum (FBS) on concanavalin A-stimulated murine splenocytes. Interleukin-2 (IL-2) secretion and
IL-2 receptor
(IL-2R) expression were determined as a function of the effect of the
acetaldehyde
-protein adduct(s). FBS was incubated with
acetaldehyde
(500, 100, 50, 25, 10, and 0 microM) for 1 hr at 37 degrees C. Excess
acetaldehyde
was removed by ultrafiltration using a 500 molecular weight cut-off membrane in 3 volumes. Free as well as bound
acetaldehyde
was quantified using fluorigenic HPLC before and after incubation. Recovered
acetaldehyde
correlated with the amount added (r2 = 0.996). Splenocytes were cultured for 48 hr in complete medium containing 5%
acetaldehyde
-treated and 5% untreated FBS with 4 micrograms/ml concanavalin A. Although cell viability was unchanged,
acetaldehyde
-treated FBS mixed with native FBS decreased IL-2 secretion in a dose-dependent manner. The percentage of cells expressing IL-2R was reduced only at the highest
acetaldehyde
-FBS dose. Therefore, immunological effects ascribed to ethanol may result in part from the toxic properties of
acetaldehyde
-protein adducts on IL-2 secretion.
...
PMID:Acetaldehyde-serum protein adducts inhibit interleukin-2 secretion in concanavalin A-stimulated murine splenocytes: a potential common pathway for ethanol-induced immunomodulation. 762 67